Decreased Vascular Permeability [PE] - N0000010252

Pharmacologic Class Information

Pharmacologic Code N0000010252
Pharmacologic Name Decreased Vascular Permeability
Pharmacologic Uses
  • human C1 esterase inhibitor
Pharmacologic Concept Physiologic Effects - [PE]
Pharmacologic Concept Description This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.

NDC Products with Decreased Vascular Permeability

The table contains 1 products whose active ingredient are classified under the same pharmacologic class Decreased Vascular Permeability [PE].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
42227-081Cinryze Non-Proprietary Name: Human C1-esterase InhibitorInjection, Powder, Lyophilized, For SolutionIntravenousTakeda Pharmaceuticals America, Inc.ACTIVE